SIETES :: 93008 citas

Resultados de la búsqueda por TRAZODONA REFINAR BÚSQUEDA

1.

Nguyen TTH, Roussin A, Rousseau A, Montastruc J-L, Montastruc F. Role of serotonin transporter in antidepressant-induced diabetes mellitus: A pharmacoepidemiological–pharmacodynamic study in VigiBase®. Drug Saf 2018;41:noviembre. [Ref.ID 102840]

2.

Gafoor R, Booth HP, Gulliford MC. Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ 2018;361:23 de mayo. [Ref.ID 102648]

3.

Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]

4.

McCormack J, Korownyk C. Effectiveness of antidepressants. BMJ 2018;360:k1073. [Ref.ID 102478]

5.

Cipriani A, Furukwa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. . Lancet 2018;391:7 de abril. [Ref.ID 102476]

6.

Hansen RN, Boudreau DM, Ebel BE, Grossman DC, Sullivan SD. Sedative hypnotic medication use and the risk of motor vehicle crash. Am J Public Health 2015;105:e64-69. [Ref.ID 99174]

7.

Coupland C, Hill TMorriss R, Arthur A, Moore M, Hippisley-Cox J. Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database. BMJ 2015;350:h517. [Ref.ID 98877]

8.

Azparren Andía A, García Romero I. Estrategias para la deprescripción de benzodiazepinas. Boletín de Información Farmacoterapéutica de Navarra 2014;22:1-12. [Ref.ID 98237]

9.

Anónimo. Benzodiacepinas: riesgos y estrategias para su retirada. Boletín Terapéutico Andaluz 2014;29:10-6. [Ref.ID 98202]

10.

Hampton LM, Daubresse M, Chang HY, Alexander C, Budnitz DS. Emergency department visits by adults for psychiatric medication adverse events. JAMA Psychiatry 2014;71:1006-14. [Ref.ID 97739]

11.

Anónimo. Study: sleep aid use in US on the rise. DIA Daily 2014:21 de febrero. [Ref.ID 97515]

12.

Anónimo. Drug-induced liver injury. Australian Prescriber 2013;36:168-9. [Ref.ID 96320]

13.

Anónimo. Tinnitus. Drug Ther Bull 2013;51:20-4. [Ref.ID 94861]

14.

Khoza S, Barner JC, Bohman TM, Rascati K, Lawson K, Wilson JP. Use of antidepressant agents and the risk of type 2 diabetes. Eur J Clin Pharmacol 2012;68:1295-302. [Ref.ID 93647]

15.

Oderda LH, Young JR, Asche CV, Pepper GA. Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs . Ann Pharmacother 2012;46:917-28. [Ref.ID 92714]

16.

Lester H, Gilbody S. Choosing a second generation antidepressant for treatment of MDD. BMJ 2012;344:11. [Ref.ID 92687]

17.

Gartlehner G. Second generation antidepressants. Fluvoxamine: winner or loser? Author's reply. BMJ 2012;344:29. [Ref.ID 92660]

18.

Straton D. Second generation antidepressants. Fluvoxamine: winner or loser?. BMJ 2012;344:29. [Ref.ID 92659]

19.

Anónimo. Donepezil - SSRI and SNRI - interactions and serotonin syndrome. WHO Pharmaceuticals Newsletter 2012;2:abril. [Ref.ID 92615]

20.

Morin CM, Benca R. Chronic insomnia. Lancet 2012;379:1129-41. [Ref.ID 92548]